Unfavorable Mortality-To-Incidence Ratio of Lung Cancer Is Associated with Health Care Disparity

Cheng-Yu Huang, Kwong-Kwok Au, Sung-Lang Chen, Shao-Chuan Wang, Chi-Yu Liao, Hui-Hsiang Hsu, Wen-Wei Sung and Yao-Chen Wang
Additional contact information
Cheng-Yu Huang: Department of Urology, National Taiwan University Hospital, Taipei 10002, Taiwan
Kwong-Kwok Au: Division of Thoracic Surgery, Department of Surgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Sung-Lang Chen: Department of Urology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Shao-Chuan Wang: Department of Urology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Chi-Yu Liao: Department of Surgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Hui-Hsiang Hsu: Department of Medical Education, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Wen-Wei Sung: Department of Urology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
Yao-Chen Wang: School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan

IJERPH, 2018, vol. 15, issue 12, 1-9

Abstract: The mortality-to-incidence ratio (MIR) is associated with the clinical outcome of cancer treatment. For several cancers, countries with relatively good health care systems have favorable MIRs. However, the association between lung cancer MIR and health care expenditures or rankings has not been evaluated. We used linear regression to analyze the correlation between lung cancer MIRs and the total expenditures on health/gross domestic product (e/GDP) and the World Health Organization (WHO) rankings. We included 57 countries, for which data of adequate quality were available, and we found high rates of incidence and mortality but low MIRs in more developed regions. Among the continents, North America had the highest rates of incidence and mortality, whereas the highest MIRs were in Africa, Asia, Latin America, and the Caribbean. Globally, favorable MIRs correlated with high e/GDP and good WHO ranking (regression coefficient, −0.014 and 0.001; p = 0.004, and p = 0.014, respectively). In conclusion, the MIR for lung cancer in different countries varies with the expenditure on health care and health system rankings.

Keywords: lung cancer; mortality; incidence; mortality-to-incidence ratio (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2018
References: View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.mdpi.com/1660-4601/15/12/2889/pdf (application/pdf)
https://www.mdpi.com/1660-4601/15/12/2889/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:15:y:2018:i:12:p:2889-:d:191098

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().